PubMed for id: 12091

Year	Number of Results
1973	2
1974	1
1976	3
1977	1
1978	3
1979	4
1981	3
1982	1
1985	1
1988	1
1989	2
1990	1
1991	4
1992	3
1994	2
1995	1
1996	3
1997	4
1998	1
1999	4
2000	4
2001	3
2002	3
2003	4
2004	3
2005	5
2006	3
2007	5
2008	3
2009	2
2010	4
2011	9
2012	1
2014	1
2015	2
2016	2
2017	4
2018	1
2019	1
2020	6
2021	2
2022	3
2023	1
2024	0

1

Increased Galactosidase Beta 1 Expression as a Senescent Key Factor in β-Cells Function Modulation at the Early Steps of Type 2 Diabetes.

Maduro AT, Pinto A, Ferreira-Gomesb J, Costa R, Soares R, Luís C. Maduro AT, et al. Exp Clin Endocrinol Diabetes. 2023 May;131(5):282-289. doi: 10.1055/a-2044-8873. Epub 2023 Apr 18. Exp Clin Endocrinol Diabetes. 2023. PMID: 37072027

2

Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis.

Weesner JA, Annunziata I, Yang T, Acosta W, Gomero E, Hu H, van de Vlekkert D, Ayala J, Qiu X, Fremuth LE, Radin DN, Cramer CL, d'Azzo A. Weesner JA, et al. Cells. 2022 Aug 19;11(16):2579. doi: 10.3390/cells11162579. Cells. 2022. PMID: 36010656 Free PMC article.

3

Endogenous pH 6.0 β-Galactosidase Activity Is Linked to Neuronal Differentiation in the Olfactory Epithelium.

de Mera-Rodríguez JA, Álvarez-Hernán G, Gañán Y, Santos-Almeida A, Martín-Partido G, Rodríguez-León J, Francisco-Morcillo J. de Mera-Rodríguez JA, et al. Cells. 2022 Jan 16;11(2):298. doi: 10.3390/cells11020298. Cells. 2022. PMID: 35053414 Free PMC article.

4

Phenotypical changes of satellite glial cells in a murine model of G_M1 -gangliosidosis.

Huang B, Zdora I, de Buhr N, Eikelberg D, Baumgärtner W, Leitzen E. Huang B, et al. J Cell Mol Med. 2022 Jan;26(2):527-539. doi: 10.1111/jcmm.17113. Epub 2021 Dec 7. J Cell Mol Med. 2022. PMID: 34877779 Free PMC article.

5

A Single Injection of an Optimized Adeno-Associated Viral Vector into Cerebrospinal Fluid Corrects Neurological Disease in a Murine Model of GM1 Gangliosidosis.

Hinderer C, Nosratbakhsh B, Katz N, Wilson JM. Hinderer C, et al. Hum Gene Ther. 2020 Nov;31(21-22):1169-1177. doi: 10.1089/hum.2018.206. Epub 2020 Nov 2. Hum Gene Ther. 2020. PMID: 33045869 Free PMC article.

6

Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.

Luu AR, Wong C, Agrawal V, Wise N, Handyside B, Lo MJ, Pacheco G, Felix JB, Giaramita A, d'Azzo A, Vincelette J, Bullens S, Bunting S, Christianson TM, Hague CM, LeBowitz JH, Yogalingam G. Luu AR, et al. J Biol Chem. 2020 Sep 25;295(39):13556-13569. doi: 10.1074/jbc.RA119.010794. Epub 2020 Jul 28. J Biol Chem. 2020. PMID: 32727849 Free PMC article.

7

Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human G_M1-Gangliosidosis.

Eikelberg D, Lehmbecker A, Brogden G, Tongtako W, Hahn K, Habierski A, Hennermann JB, Naim HY, Felmy F, Baumgärtner W, Gerhauser I. Eikelberg D, et al. J Clin Med. 2020 Apr 2;9(4):1004. doi: 10.3390/jcm9041004. J Clin Med. 2020. PMID: 32252429 Free PMC article.

8

Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.

Chen JC, Luu AR, Wise N, Angelis R, Agrawal V, Mangini L, Vincelette J, Handyside B, Sterling H, Lo MJ, Wong H, Galicia N, Pacheco G, Van Vleet J, Giaramita A, Fong S, Roy SM, Hague C, Lawrence R, Bullens S, Christianson TM, d'Azzo A, Crawford BE, Bunting S, LeBowitz JH, Yogalingam G. Chen JC, et al. J Biol Chem. 2020 Sep 25;295(39):13532-13555. doi: 10.1074/jbc.RA119.009811. Epub 2019 Sep 3. J Biol Chem. 2020. PMID: 31481471 Free PMC article.

9

Is senescence-associated β-galactosidase a marker of neuronal senescence?

Piechota M, Sunderland P, Wysocka A, Nalberczak M, Sliwinska MA, Radwanska K, Sikora E. Piechota M, et al. Oncotarget. 2016 Dec 6;7(49):81099-81109. doi: 10.18632/oncotarget.12752. Oncotarget. 2016. PMID: 27768595 Free PMC article.

10

B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.

Sun JB, Czerkinsky C, Holmgren J. Sun JB, et al. J Immunol. 2012 Feb 15;188(4):1686-97. doi: 10.4049/jimmunol.1101771. Epub 2012 Jan 16. J Immunol. 2012. PMID: 22250081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year